2022
Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review
Guiducci S, Meggiolaro L, Righetto A, Piccoli M, Baraldi E, Galderisi A. Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review. Children 2022, 9: 1541. PMID: 36291477, PMCID: PMC9600957, DOI: 10.3390/children9101541.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsGriffiths Mental Developmental ScalesInternational trial registriesPreterm infantsNeonatal hyperglycemiaYears of lifeNeurodevelopmental outcomesEarly neonatal hyperglycemiaCochrane Central RegisterLong-term neurodevelopmentQuality of evidenceEffects of hyperglycemiaMovement Assessment BatteryGlucose impairmentCentral RegisterControlled TrialsNeurodevelopment outcomeTrials RegistryCochrane LibraryNeurodevelopment assessmentNeurological delayMotor functionCurrent evidencePRISMA guidelinesHyperglycemiaBayley Scales
2020
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants
Galderisi A, Bruschettini M, Russo C, Hall R, Trevisanuto D. Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants. 2020, 12: cd013309. PMID: 33348448, PMCID: PMC8092644, DOI: 10.1002/14651858.cd013309.pub2.Peer-Reviewed Original ResearchConceptsPreterm infantsContinuous glucose monitoringGlycemic measuresRisk ratioIntermittent modalitiesLong-term neurodevelopmental impairmentGlucose monitoringCare Group (EPOC) criteriaCochrane Central RegisterCochrane Effective PracticePrevention of morbidityQuasi-randomized trialStandard search strategyClinical trials databasesLong-term outcomesPreterm infant mortalityAllied Health LiteratureUse of CGMImprecision of estimatesFixed-effects modelCochrane NeonatalAdverse neurodevelopmentCentral RegisterGRADE approachControlled Trials